Call Options

17 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q1 2024

May 15, 2024

SELL
$127.73 - $147.2 $1.53 Million - $1.77 Million
-12,000 Reduced 67.04%
5,900 $810,000
Q4 2023

Feb 14, 2024

BUY
$92.79 - $142.53 $1.08 Million - $1.65 Million
11,600 Added 184.13%
17,900 $2.49 Million
Q3 2023

Nov 14, 2023

BUY
$128.91 - $192.44 $348,057 - $519,588
2,700 Added 75.0%
6,300 $864,000
Q2 2023

Aug 14, 2023

BUY
$183.43 - $232.67 $366,860 - $465,340
2,000 Added 125.0%
3,600 $674,000
Q1 2023

May 15, 2023

SELL
$193.75 - $232.55 $561,875 - $674,395
-2,900 Reduced 64.44%
1,600 $372,000
Q4 2022

Feb 14, 2023

SELL
$187.24 - $242.74 $74,896 - $97,096
-400 Reduced 8.16%
4,500 $909,000
Q3 2022

Nov 14, 2022

BUY
$177.23 - $227.44 $159,507 - $204,696
900 Added 22.5%
4,900 $935,000
Q2 2022

Aug 15, 2022

BUY
$181.58 - $368.0 $581,056 - $1.18 Million
3,200 Added 400.0%
4,000 $737,000
Q2 2021

Aug 16, 2021

BUY
$372.84 - $481.5 $298,272 - $385,200
800 New
800 $379,000
Q1 2021

May 17, 2021

SELL
$361.28 - $504.76 $433,535 - $605,712
-1,200 Closed
0 $0
Q4 2020

Feb 16, 2021

SELL
$292.7 - $370.96 $1.08 Million - $1.37 Million
-3,700 Reduced 75.51%
1,200 $444,000
Q3 2020

Nov 16, 2020

BUY
$268.51 - $400.74 $939,785 - $1.4 Million
3,500 Added 250.0%
4,900 $1.51 Million
Q2 2020

Sep 10, 2020

BUY
$256.46 - $373.01 $359,044 - $522,214
1,400 New
1,400 $518,000
Q1 2020

May 15, 2020

SELL
$209.2 - $335.53 $2.34 Million - $3.76 Million
-11,200 Closed
0 $0
Q4 2019

Feb 14, 2020

BUY
$288.29 - $335.49 $2.42 Million - $2.82 Million
8,400 Added 300.0%
11,200 $3.72 Million
Q2 2019

Aug 14, 2019

BUY
$300.59 - $368.15 $360,707 - $441,780
1,200 Added 75.0%
2,800 $1.03 Million
Q1 2019

May 15, 2019

BUY
$272.57 - $321.18 $436,112 - $513,888
1,600 New
1,600 $497,000

Others Institutions Holding ILMN

About ILLUMINA, INC.


  • Ticker ILMN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 157,300,000
  • Market Cap $22B
  • Description
  • Illumina, Inc. provides sequencing and array-based solutions for genetic and genomic analysis. Its products and services serve customers in a range of markets enabling the adoption of genomic solutions in research and clinical settings for applications in the life sciences, oncology, reproductive health, agriculture, and other emerging segments....
More about ILMN
Track This Portfolio

Track Two Sigma Securities, LLC Portfolio

Follow Two Sigma Securities, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Two Sigma Securities, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Two Sigma Securities, LLC with notifications on news.